Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents
- PMID: 22296357
Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents
Abstract
Liver cancer is one of the three most common causes of cancer mortality in the world and it is closely related to chronic hepatitis B viral (HBV) infection in Korea. The decline of HBV prevalence for the last two decades in Korea might be partly due to the HBV vaccination, which was implemented as a national program starting in 1995. The aim of this study was to assess the period effect of the national HBV vaccination on liver cancer mortality in a young population. We compared age-specific mortality rates of liver cancer before and after the national vaccination program in the Korean population under the age of 20. To reduce year-to-year fluctuations in mortality, calendar years and age groups were divided into 4-year strata and the mortality rates were calculated for each stratum. Period effects of the national vaccination program were analyzed using age-period-cohort modeling. A total of 370 liver cancer mortality cases were identified during the period from 1991 to 2006. The period effect of the national vaccination program for the period 2002-2006 had a significantly reduced liver cancer mortality rate when compared to the period 1991-1994 when the national vaccination program was not implemented (RR 0.30, 95% CI 0.21~0.44). After implementation of the national vaccination program, HBV prevalence in Korean declined from 6~8% to 2~3%. This study demonstrates that the national vaccination program has contributed to the reduction of liver cancer mortality beyond just a natural decrease in Korean children and adolescents.
Similar articles
-
Viral hepatitis and liver cancer in Korea: an epidemiological perspective.Asian Pac J Cancer Prev. 2013;14(11):6227-31. doi: 10.7314/apjcp.2013.14.11.6227. Asian Pac J Cancer Prev. 2013. PMID: 24377509 Review.
-
Hepatitis B vaccination in children: the Taiwan experience.Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29. Pathol Biol (Paris). 2010. PMID: 20116181
-
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.Int J Epidemiol. 2005 Dec;34(6):1329-39. doi: 10.1093/ije/dyi206. Epub 2005 Oct 25. Int J Epidemiol. 2005. PMID: 16249217
-
Secular trends were considered in the evaluation of universal hepatitis B vaccination in Taiwan.J Clin Epidemiol. 2015 Apr;68(4):405-11. doi: 10.1016/j.jclinepi.2014.11.014. Epub 2014 Dec 13. J Clin Epidemiol. 2015. PMID: 25660961
-
Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period.Intervirology. 2010;53(1):20-8. doi: 10.1159/000252780. Epub 2010 Jan 5. Intervirology. 2010. PMID: 20068337 Review.
Cited by
-
Long-Term Trend of Liver Cancer Mortality in Serbia, 1991-2015: An Age-Period-Cohort and Joinpoint Regression Analysis.Healthcare (Basel). 2020 Aug 21;8(3):283. doi: 10.3390/healthcare8030283. Healthcare (Basel). 2020. PMID: 32825549 Free PMC article.
-
Vaccines for immunoprevention of cancer.J Clin Invest. 2021 May 3;131(9):e146956. doi: 10.1172/JCI146956. J Clin Invest. 2021. PMID: 33938446 Free PMC article. Review.
-
Early-life exposures to infectious agents and later cancer development.Cancer Med. 2015 Dec;4(12):1908-22. doi: 10.1002/cam4.538. Epub 2015 Sep 17. Cancer Med. 2015. PMID: 26377256 Free PMC article. Review.
-
Emerging strategies for cancer immunoprevention.Oncogene. 2015 Dec 10;34(50):6029-39. doi: 10.1038/onc.2015.98. Epub 2015 Sep 14. Oncogene. 2015. PMID: 26364615 Free PMC article. Review.
-
Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.PLoS Med. 2014 Dec 30;11(12):e1001774. doi: 10.1371/journal.pmed.1001774. eCollection 2014 Dec. PLoS Med. 2014. PMID: 25549238 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical